Whether you have personal experience with cosmetic surgery or not, this corner of the economy is probably larger than you imagine. Grandview Research recently valued the global cosmetic surgery and ...

InMode's Q4 revenue dropped YOY; management optimistic about new platforms despite industry challenges. High dependence on U.S. revenue from minimally invasive procedures; facing increasing ...

Forbes contributors publish independent expert analyses and insights. Meggen Harris writes about entrepreneurs in beauty and wellness. Now that I am officially divorced, I decided to embark on a few ...

InMode is a medical device maker that specializes in minimally invasive treatments with results that resemble those of liposuction. The average price target on Wall Street for InMode represents a 47% ...

InMode shares experienced a significant drop of 20% in one trading day, but the decline is seen as excessively harsh. InMode's unique product line bridges the gap between surgical procedures and ...

InMode Ltd (NASDAQ:INMD) reflects healthcare technology trends and valuation positioning amid Nasdaq today movement.

We recently compiled a list of the 10 Best Cosmetic Surgery and Aesthetics Stocks To Buy. In this article, we are going to take a look at where InMode Ltd. (NASDAQ:INMD) stands against the other ...

InMode specializes in making equipment for less-invasive aesthetic procedures. Medtronic is one of the largest equipment makers in the world. Medtronic offers an above-average dividend. Medical stocks ...

InMode (NASDAQ:INMD) is a promising aesthetic medical product player. Its proprietary radio frequency platform is the focal point of its innovative product offering. However, the company’s financial ...

InMode's CFO says a multi-year demand downturn is beginning to stabilize and management is targeting 2026 revenue to be "flat", while noting patient demand is the primary headwind and higher interest ...